![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » FDA Clears Cerebrotech Neurological Spectroscopy Device
FDA Clears Cerebrotech Neurological Spectroscopy Device
![FDA_Logo_Blue_2016.gif](https://www.fdanews.com/ext/resources/test/Drug-Images4/FDA_Logo_Blue_2016.gif?t=1578316591&width=430)
January 10, 2018
The FDA cleared Cerebrotech Medical Systems’ Cerebrotech Visor, a bioimpedance spectroscopy device designed to aid clinicians in assessing cerebral fluid volumes.
The clearance includes a broad indication for use in assessing fluid volume differences between the cerebral hemispheres in patients undergoing neurologic assessment.
The device features the company’s proprietary machine learning technology for optimizing algorithms.
Upcoming Events
-
21Oct